Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges 
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny 
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network 
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure 
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration 
Starlink Internet Remains Active in Iran Despite Nationwide Blackout 
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes 
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand 
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026 
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals 
LOS ANGELES, March 24, 2017 -- Lundin Law PC, a shareholder rights firm announces a class action lawsuit against Aetna Inc. (“Aetna” or the “Company”) (NYSE:AET) concerning possible violations of federal securities laws. Investors who purchased or otherwise acquired shares between August 15, 2016 and January 20, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the March 27, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here, or call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at [email protected].
No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.
The Complaint alleges that during the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: Aetna and its senior executives tried to influence Aetna's participation in the Public Exchanges for positive treatment from regulators regarding the Humana acquisition; that the Company threatened to cut back its participation in public health insurance exchanges if the Department of Justice ("DOJ") tried to block the merger; that Aetna withdraw from some public health insurance exchanges to complete its threat of leaving the marketplace once the DOJ filed suit to better its litigation; that Aetna withdrew from public health insurance exchanges that were profitable for Aetna; and that due to the above, Defendants' statements regarding Aetna's business, operations, and prospects were false and misleading and/or lacked a reasonable basis.
When this information was released to the public, the value of Aetna stock fell, causing investors harm.
Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders' rights.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact: Lundin Law PC Brian Lundin, Esq. Telephone: 888-713-1033 Facsimile: 888-713-1125 [email protected]
